drugset
drugset / Trial / NCT03717064

A Study to Investigate the Effect of RO7049389 on the Pharmacokinetics of Pitavastatin in Healthy Volunteers

NCT03717064 ↗

Phase 1 Completed 18 enrolled Hoffmann-La Roche
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The main purpose of the study is to characterize the interaction between RO7049389 and the cholesterol-lowering drug, pitavastatin, in healthy volunteers. There is no intended clinical benefit to this study. The total duration of the study for each participant is approximately 12 weeks.

Timeline

Start
2018-11-07
Primary completion
2018-12-17
Completion
2018-12-17

Drugs

EvaluationDrugModalityDoseRoute
Subject LINVENCORVIR Small molecule — Oral
Subject Pitavastatin Small molecule — Oral

Indications

No indication recorded.